ArticleJournal of current ophthalmology
Advancing Glaucoma Treatment through Materials Science: A Bibliometric Analysis.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging Preclinical and Clinical Gaps in Ocular Therapeutics: Hydrogel Drug Delivery and 3D Tissue Models.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To identify recent research trends on advancing glaucoma treatment through materials science and focus on publications from different countries, institutions, and authors. Methods: We retrieved and analyzed data from January 1, 2015, to October 24, 2024, on the advancing glaucoma treatment through materials science research field from the Web of Science Core Collection database. Microsoft Excel and VOSviewer were applied to perform visualization analysis and evaluate the trends. Results: A total of 936 publications were identified, and the annual global publications increased steadily, from 44 to 93, during this period. The United States (267 publications, 9934 citations), Egyptian Knowledge Bank (52 publications, 1262 citations), and Jui-Yang Lai (20 publications, 986 citations) were the most influential and productive countries, institutions, and authors, respectively. The top 100 keywords were classified into eight clusters: (1) surgical materials; (2) nanoparticle retinal protection; (3) eye drops; (4) drug delivery characteristics; (5) contact; (6) ocular drug delivery mechanisms; (7) bioavailability and optimization; and (8) release technologies. Regarding the average appearing years (AAYs) of the keywords, "microshunt" (AAY: 2023.25), "MIGS" (AAY: 2022), and "d-optimal design" (AAY: 2021.5) were recognized as the hotspots in the short run. Conclusions: This study highlights advancements in materials science for glaucoma treatment, including biomaterials, nanotechnology, and nanoengineering. These innovations enable better drug delivery, improved devices, and surgical materials, promising more effective, personalized, and minimally invasive therapies for improved patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.